In summary, WAC reduces TG synthesis in liver and HepG2 cells by activating PI3K/AKT pathway and AMPK to decrease SREBP-1c expression and alleviate hepatic steatosis. The gene discussed is AKT1; the disease is Hepatic steatosis.